Alert
Please keep in mind that merely contacting Nelson Mullins Riley & Scarborough LLP will not establish an attorney-client relationship. Nelson Mullins cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement. Accordingly, please do not send Nelson Mullins any information or documents until a formal attorney-client relationship has been established through an interview with an attorney and authorized in the form of an engagement letter from Nelson Mullins. Any information or documents sent prior to your receipt of an engagement letter cannot be treated as confidences, secrets or protected information of any nature. Clicking "Submit" acknowledges that you understand and agree with this notice.
The LatestView All
December 5, 2023
Nelson Mullins partner Bernie F. Hawkins Jr. is apart of the planning committee for the event, which will be hosted partially at Nelson Mullins' offices in Atlanta and Columbia — as well as locations in Washington, D.C.; Austin, Texas; Chicago; Denver, Colorado; Houston, Texas; and Kansas City, Missouri.
2023 Clean Air Act Conference
Idea Exchange
Monee Hanna
Partner
Pacific Gateway
19191 South Vermont Avenue
Suite 900
Torrance, CA 90502
19191 South Vermont Avenue
Suite 900
Torrance, CA 90502
monee.hanna@nelsonmullins.com
Monee focuses her practice on the representation of pharmaceutical and medical device manufacturers in complex product liability litigation across the country. She also has experience in business litigation matters, including class actions, unfair competition claims, and antitrust actions.
Monee focuses her practice on the representation of pharmaceutical and medical device manufacturers in complex product liability litigation across the country. She also has experience in business litigation matters, including class actions, unfair competition claims, and antitrust actions.
Experience
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
- Defended transdermal drug-delivery systems, diabetes medication, pelvic mesh, surgical devices, and cardiac medication actions in state and federal courts
- Served as national counsel defending personal injury claims related to silicone gel and saline breast implants and tissue expanders
- Obtained dismissal for medical device company in case involving alleged injuries from ruptured silicone gel breast implants (E.D. Mo. 2019), affirmed on appeal (8th Cir. 2021)
- Obtained dismissals for medical device company on federal preemption under Riegel in four multi-plaintiff cases involving alleged injuries from ruptured silicone gel breast implants (C.D. Cal. 2019), affirmed on appeal (9th Cir. 2021)
- Obtained dismissal for medical device company on federal preemption under Riegel in two-plaintiff case involving alleged injuries from ruptured silicone gel breast implants (D. Kan. 2019), affirmed on appeal (10th Cir. 2021)
- Obtained dismissal for medical device company on federal preemption under Riegel and Connecticut Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (D.N.J. 2020)
- Obtained dismissals for medical device company on federal preemption under Riegel in cases involving alleged injuries from silicone gel breast implants (N.D.N.Y. 2020, D. Md. 2020)
- Obtained dismissal for medical device company on federal preemption under Riegel in cases involving alleged injuries from saline breast implants (S.D. Florida 2019, N.D. Ohio 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (M.D. Fla. 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (W.D. Wash. 2018)
- Obtained dismissal for medical device company on federal preemption under Riegel and Ohio Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (N.J. Sup. Ct. Law Div. Middlesex Cty 2018)
- Obtained summary judgment for medical device company on federal preemption under Riegel and for lack of defect or causation in case involving alleged mold toxicity from saline breast implants, following exclusion of plaintiff’s three experts under Daubert (C.D. Cal. 2017), affirmed on appeal (9th Cir. 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries allegedly caused by ruptured silicone gel breast implant (D.S.C. 2014)
- Obtained summary judgment for medical device company for lack of defect in case involving injuries allegedly caused by leaking tissue expander (N.J. Super. Ct. Law Div. Atlantic Cty 2014)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries caused by ruptured saline breast implant (E.D. Cal. 2012)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving Class III stair-climbing wheelchair (E.D. Cal. 2011)
Education
-
Harvard Law School,
JD
(2008)
- Harvard Civil Rights-Civil Liberties Law Review, General Editor
-
University of California Los Angeles,
BA,
cum laude
(2005)
- Phi Beta Kappa
Admissions
- California
- U.S. District Court for the Central District of California
- U.S. District Court for the Eastern District of California
- U.S. District Court for the Northern District of California
- U.S. District Court for the Southern District of California
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
- Defended transdermal drug-delivery systems, diabetes medication, pelvic mesh, surgical devices, and cardiac medication actions in state and federal courts
- Served as national counsel defending personal injury claims related to silicone gel and saline breast implants and tissue expanders
- Obtained dismissal for medical device company in case involving alleged injuries from ruptured silicone gel breast implants (E.D. Mo. 2019), affirmed on appeal (8th Cir. 2021)
- Obtained dismissals for medical device company on federal preemption under Riegel in four multi-plaintiff cases involving alleged injuries from ruptured silicone gel breast implants (C.D. Cal. 2019), affirmed on appeal (9th Cir. 2021)
- Obtained dismissal for medical device company on federal preemption under Riegel in two-plaintiff case involving alleged injuries from ruptured silicone gel breast implants (D. Kan. 2019), affirmed on appeal (10th Cir. 2021)
- Obtained dismissal for medical device company on federal preemption under Riegel and Connecticut Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (D.N.J. 2020)
- Obtained dismissals for medical device company on federal preemption under Riegel in cases involving alleged injuries from silicone gel breast implants (N.D.N.Y. 2020, D. Md. 2020)
- Obtained dismissal for medical device company on federal preemption under Riegel in cases involving alleged injuries from saline breast implants (S.D. Florida 2019, N.D. Ohio 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (M.D. Fla. 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (W.D. Wash. 2018)
- Obtained dismissal for medical device company on federal preemption under Riegel and Ohio Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (N.J. Sup. Ct. Law Div. Middlesex Cty 2018)
- Obtained summary judgment for medical device company on federal preemption under Riegel and for lack of defect or causation in case involving alleged mold toxicity from saline breast implants, following exclusion of plaintiff’s three experts under Daubert (C.D. Cal. 2017), affirmed on appeal (9th Cir. 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries allegedly caused by ruptured silicone gel breast implant (D.S.C. 2014)
- Obtained summary judgment for medical device company for lack of defect in case involving injuries allegedly caused by leaking tissue expander (N.J. Super. Ct. Law Div. Atlantic Cty 2014)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries caused by ruptured saline breast implant (E.D. Cal. 2012)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving Class III stair-climbing wheelchair (E.D. Cal. 2011)
Media
Community
- Legal Aid Foundation of Los Angeles Associate Advisory Board (2014-present; Board secretary 2020-2022)
- Pro bono attorney, Alliance for Children’s Rights (2012-present)
Monee focuses her practice on the representation of pharmaceutical and medical device manufacturers in complex product liability litigation across the country. She also has experience in business litigation matters, including class actions, unfair competition claims, and antitrust actions.
Experience
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.- Defended transdermal drug-delivery systems, diabetes medication, pelvic mesh, surgical devices, and cardiac medication actions in state and federal courts
- Served as national counsel defending personal injury claims related to silicone gel and saline breast implants and tissue expanders
- Obtained dismissal for medical device company in case involving alleged injuries from ruptured silicone gel breast implants (E.D. Mo. 2019), affirmed on appeal (8th Cir. 2021)
- Obtained dismissals for medical device company on federal preemption under Riegel in four multi-plaintiff cases involving alleged injuries from ruptured silicone gel breast implants (C.D. Cal. 2019), affirmed on appeal (9th Cir. 2021)
- Obtained dismissal for medical device company on federal preemption under Riegel in two-plaintiff case involving alleged injuries from ruptured silicone gel breast implants (D. Kan. 2019), affirmed on appeal (10th Cir. 2021)
- Obtained dismissal for medical device company on federal preemption under Riegel and Connecticut Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (D.N.J. 2020)
- Obtained dismissals for medical device company on federal preemption under Riegel in cases involving alleged injuries from silicone gel breast implants (N.D.N.Y. 2020, D. Md. 2020)
- Obtained dismissal for medical device company on federal preemption under Riegel in cases involving alleged injuries from saline breast implants (S.D. Florida 2019, N.D. Ohio 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (M.D. Fla. 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving alleged injuries from ruptured silicone gel breast implants (W.D. Wash. 2018)
- Obtained dismissal for medical device company on federal preemption under Riegel and Ohio Product Liability Act abrogation in case involving alleged breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from silicone gel breast implants (N.J. Sup. Ct. Law Div. Middlesex Cty 2018)
- Obtained summary judgment for medical device company on federal preemption under Riegel and for lack of defect or causation in case involving alleged mold toxicity from saline breast implants, following exclusion of plaintiff’s three experts under Daubert (C.D. Cal. 2017), affirmed on appeal (9th Cir. 2019)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries allegedly caused by ruptured silicone gel breast implant (D.S.C. 2014)
- Obtained summary judgment for medical device company for lack of defect in case involving injuries allegedly caused by leaking tissue expander (N.J. Super. Ct. Law Div. Atlantic Cty 2014)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving injuries caused by ruptured saline breast implant (E.D. Cal. 2012)
- Obtained dismissal for medical device company on federal preemption under Riegel in case involving Class III stair-climbing wheelchair (E.D. Cal. 2011)
Education
-
Harvard Law School,
JD
(2008)
- Harvard Civil Rights-Civil Liberties Law Review, General Editor
-
University of California Los Angeles,
BA,
cum laude
(2005)
- Phi Beta Kappa
Admissions
- California
- U.S. District Court for the Central District of California
- U.S. District Court for the Eastern District of California
- U.S. District Court for the Northern District of California
- U.S. District Court for the Southern District of California
Practice Areas
- Legal Aid Foundation of Los Angeles Associate Advisory Board (2014-present; Board secretary 2020-2022)
- Pro bono attorney, Alliance for Children’s Rights (2012-present)
Highlights from the Firm’s Idea Exchange
'Missing Middle' Property Tax Exemption Now Available
November 29, 2023
You Can't be an Expert at Everything
November 21, 2023
TRIBAL ROUNDTABLE – PROPOSED Bureau of Indian Affairs CHANGES: PARTS...
November 21, 2023
Turkeys Pardoned – New Share Repurchase Rule Delayed – Is...
November 27, 2023
IRS Process for Withdrawing Employee Retention Credit Claims
November 16, 2023
The National Law Review - The SEC’s New Clawback Rules:...
November 15, 2023